WebMar 24, 2024 · Context Therapeutics Inc CNTX:NASDAQ EXPORT WATCHLIST + RT Quote Last NASDAQ LS, VOL From CTA USD After Hours: Last 03/24/23 EDT 0.62 … WebMar 29, 2024 · Context Therapeutics Inc. (NASDAQ:CNTX – Get Rating) – HC Wainwright issued their Q1 2024 earnings per share (EPS) estimates for Context Therapeutics in a research report issued on Thursday, March 23rd.HC Wainwright analyst E. Bodnar expects that the company will post earnings per share of ($0.16) for the quarter. HC Wainwright …
Context Therapeutics Inc. (CNTX) - Yahoo Finance
Web2 hours ago · CNTX + Free Alerts is a biopharmaceutical company committed to advancing medicines for solid tumors by harnessing novel and innovative treatment targets such as … WebA number of insiders bought Context Therapeutics Inc. (NASDAQ:CNTX) stock last year, which is great news for shareholders. Generally, when a single insider buys stock, it is usually not a big deal ... crvena bela plava zastava
Context Therapeutics Inc. (CNTX) - Stock Analysis
WebCNTX : 0.6051 (+3.42%) Context Therapeutics and The Menarini Group Announce Clinical Trial Collaboration and Supply Agreement to Evaluate ONA-XR and Elacestrant Combination Newswire.ca - Tue Aug 2, 2024. /CNW/ -- Context Therapeutics Inc. ("Context" or the "Company") (Nasdaq: CNTX), a women's oncology company developing small … WebMar 22, 2024 · PHILADELPHIA, PA— March 22, 2024—Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a biopharmaceutical company developing novel treatments for solid tumors, today announced financial results for the year ended December 31, 2024.Additionally, the Company announced a portfolio prioritization and … WebOn Invalid Date, Context Therapeutics (NASDAQ: CNTX) reported Q4 2024 earnings per share (EPS) of -$0.22, up 101.29% year over year. Total Context Therapeutics earnings … اغاني سيف نبيل حزينه جدا